Wellcome Centres aim to advance our understanding of health and disease, and span fundamental and social sciences, clinical research and engineering.
The Wellcome Centre for Neuroimaging at UCL Institute of Neurology led by Professor Cathy Price has been renewed for a further five years with a funding injection of £11M.
The new vision for the department is to deliver clinically transformative applications of neuroimaging. This will include technological developments including a wearable MEG system that can be used in the clinic and new computationally based analyses that aim to improve diagnosis, prognosis and treatment planning in neurological and psychiatric disorders. Professor Cathy Price, Director, Wellcome Centre for Neuroimaging, UCL Institute of Neurology
The Centre (incorporating the Leopold Muller Functional Imaging Laboratory and the Wellcome Department of Imaging Neuroscience) is an interdisciplinary centre for neuroimaging excellence. It brings together clinicians and scientists who study higher cognitive function using neuroimaging techniques. Research groups study all aspects of higher cognitive function including vision, hearing, memory, language, reasoning, emotion, decision making and social interactions.
“Wellcome Centres play a special role in the global research ecosystem. By creating places where researchers can flourish we can catalyse world-leading research and translation, and amplify its influence and impact. “At Wellcome we believe in long term support for discovery-driven science, and Wellcome Centres are an outstanding environment for researchers to further our understanding of fundamental biology, accelerate translation to clinical practice, and explore the social and cultural context of medicine." Wellcome’s Director Dr Jeremy Farrar